AMERICAS GOLD AND SILVER COR (USAS) Fundamental Analysis & Valuation

NYSEARCA:USAS • CA03062D8035

Current stock price

5.87 USD
+0.15 (+2.62%)
At close:
5.86 USD
-0.01 (-0.17%)
After Hours:

This USAS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. USAS Profitability Analysis

1.1 Basic Checks

  • In the past year USAS has reported negative net income.
  • In the past year USAS has reported a negative cash flow from operations.
  • USAS had negative earnings in each of the past 5 years.
  • USAS had a negative operating cash flow in each of the past 5 years.
USAS Yearly Net Income VS EBIT VS OCF VS FCFUSAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • USAS has a worse Return On Assets (-21.17%) than 78.53% of its industry peers.
  • The Return On Equity of USAS (-39.46%) is worse than 80.37% of its industry peers.
Industry RankSector Rank
ROA -21.17%
ROE -39.46%
ROIC N/A
ROA(3y)-21.29%
ROA(5y)-32.07%
ROE(3y)-59.08%
ROE(5y)-79.93%
ROIC(3y)N/A
ROIC(5y)N/A
USAS Yearly ROA, ROE, ROICUSAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • USAS has a Gross Margin of 28.04%. This is in the better half of the industry: USAS outperforms 62.58% of its industry peers.
  • In the last couple of years the Gross Margin of USAS has grown nicely.
  • USAS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.66%
GM growth 5YN/A
USAS Yearly Profit, Operating, Gross MarginsUSAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. USAS Health Analysis

2.1 Basic Checks

  • USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, USAS has more shares outstanding
  • The number of shares outstanding for USAS has been increased compared to 5 years ago.
  • The debt/assets ratio for USAS is higher compared to a year ago.
USAS Yearly Shares OutstandingUSAS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
USAS Yearly Total Debt VS Total AssetsUSAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 3.13 indicates that USAS is not in any danger for bankruptcy at the moment.
  • USAS's Altman-Z score of 3.13 is in line compared to the rest of the industry. USAS outperforms 46.63% of its industry peers.
  • USAS has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • USAS's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. USAS outperforms 41.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 3.13
ROIC/WACCN/A
WACC12.15%
USAS Yearly LT Debt VS Equity VS FCFUSAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • USAS has a Current Ratio of 1.78. This is a normal value and indicates that USAS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of USAS (1.78) is worse than 61.96% of its industry peers.
  • USAS has a Quick Ratio of 1.66. This is a normal value and indicates that USAS is financially healthy and should not expect problems in meeting its short term obligations.
  • USAS has a Quick ratio of 1.66. This is comparable to the rest of the industry: USAS outperforms 53.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.66
USAS Yearly Current Assets VS Current LiabilitesUSAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. USAS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.44% over the past year.
  • The Revenue has grown by 17.71% in the past year. This is quite good.
  • USAS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.43% yearly.
EPS 1Y (TTM)34.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)17.71%
Revenue growth 3Y11.53%
Revenue growth 5Y33.43%
Sales Q2Q%31.4%

3.2 Future

  • Based on estimates for the next years, USAS will show a very strong growth in Earnings Per Share. The EPS will grow by 26.99% on average per year.
  • USAS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.68% yearly.
EPS Next Y192.02%
EPS Next 2Y96.54%
EPS Next 3Y60.05%
EPS Next 5Y26.99%
Revenue Next Year154.15%
Revenue Next 2Y97.3%
Revenue Next 3Y56.93%
Revenue Next 5Y19.68%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
USAS Yearly Revenue VS EstimatesUSAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
USAS Yearly EPS VS EstimatesUSAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. USAS Valuation Analysis

4.1 Price/Earnings Ratio

  • USAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 21.62 indicates a rather expensive valuation of USAS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of USAS is on the same level as its industry peers.
  • USAS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.36.
Industry RankSector Rank
PE N/A
Fwd PE 21.62
USAS Price Earnings VS Forward Price EarningsUSAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAS Per share dataUSAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • USAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • USAS's earnings are expected to grow with 60.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.54%
EPS Next 3Y60.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USAS Dividend Analysis

5.1 Amount

  • USAS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USAS Fundamentals: All Metrics, Ratios and Statistics

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (5/1/2026, 8:04:00 PM)

After market: 5.86 -0.01 (-0.17%)

5.87

+0.15 (+2.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength81.1
Industry Growth11.94
Earnings (Last)03-30
Earnings (Next)05-07
Inst Owners39.15%
Inst Owner Change0.06%
Ins Owners5.51%
Ins Owner Change0%
Market Cap1.61B
Revenue(TTM)117.93M
Net Income(TTM)-87.45M
Analysts80
Price Target8.55 (45.66%)
Short Float %3.94%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-660.07%
Min EPS beat(2)-826.07%
Max EPS beat(2)-494.06%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-8.83%
Max Revenue beat(2)9.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30.99%
PT rev (3m)67.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)11.91%
EPS NY rev (3m)82.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.72%
Revenue NY rev (3m)40.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.62
P/S 13.62
P/FCF N/A
P/OCF N/A
P/B 7.25
P/tB 7.25
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)0.27
Fwd EY4.62%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.43
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.17%
ROE -39.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.04%
FCFM N/A
ROA(3y)-21.29%
ROA(5y)-32.07%
ROE(3y)-59.08%
ROE(5y)-79.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.66%
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 326.08%
Cap/Sales 58.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.66
Altman-Z 3.13
F-Score4
WACC12.15%
ROIC/WACCN/A
Cap/Depr(3y)166.66%
Cap/Depr(5y)134.38%
Cap/Sales(3y)32.83%
Cap/Sales(5y)29.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y192.02%
EPS Next 2Y96.54%
EPS Next 3Y60.05%
EPS Next 5Y26.99%
Revenue 1Y (TTM)17.71%
Revenue growth 3Y11.53%
Revenue growth 5Y33.43%
Sales Q2Q%31.4%
Revenue Next Year154.15%
Revenue Next 2Y97.3%
Revenue Next 3Y56.93%
Revenue Next 5Y19.68%
EBIT growth 1Y3.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1924.17%
EBIT Next 3Y203.81%
EBIT Next 5Y77.12%
FCF growth 1Y-233.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.59%
OCF growth 3YN/A
OCF growth 5YN/A

AMERICAS GOLD AND SILVER COR / USAS Fundamental Analysis FAQ

What is the fundamental rating for USAS stock?

ChartMill assigns a fundamental rating of 3 / 10 to USAS.


What is the valuation status for USAS stock?

ChartMill assigns a valuation rating of 2 / 10 to AMERICAS GOLD AND SILVER COR (USAS). This can be considered as Overvalued.


Can you provide the profitability details for AMERICAS GOLD AND SILVER COR?

AMERICAS GOLD AND SILVER COR (USAS) has a profitability rating of 1 / 10.


How financially healthy is AMERICAS GOLD AND SILVER COR?

The financial health rating of AMERICAS GOLD AND SILVER COR (USAS) is 3 / 10.